Here, we demonstrate that this pharmacological approach, using the non-specific HIF hydroxylase inhibitor DMOG, was able to stabilize HIF-1α in IR cells, and improve recovery of cardiac function post-ischemia in diabetic rats. Here, HIF1A is linked to ischemia.